Integrated Diagnostics (LON:IDHC) Reaches New 12-Month High – Time to Buy?
by Mitch Edgeman · The Markets DailyShares of Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 0.72 and last traded at GBX 0.69, with a volume of 213899 shares trading hands. The stock had previously closed at GBX 0.69.
Integrated Diagnostics Trading Down 4.2%
The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 45.72. The company has a market capitalization of £3.95 million, a PE ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.59. The stock’s fifty day moving average price is GBX 0.62 and its two-hundred day moving average price is GBX 0.50.
Integrated Diagnostics Company Profile
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.